Pharmaceuticals : Shots - Health News Pharmaceuticals

The hepatitis C medication Sovaldi, from Gilead Sciences, costs $1,000 per pill. It's just one of the new medications introduced in the past year that can cure the disease within weeks or months. Courtesy of Gilead Sciences via AP hide caption

toggle caption
Courtesy of Gilead Sciences via AP

Costly Hepatitis C Drugs Threaten To Bust Prison Budgets

  • Download
  • <iframe src="https://www.npr.org/player/embed/372721256/372837243" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Katie Clapp shares a laugh with her son Andy Tranfaglia, 25, at their home in West Newbury, Mass. Andy has a rare genetic condition called fragile X syndrome. Ellen Webber for NPR hide caption

toggle caption
Ellen Webber for NPR

A Family's Long Search For Fragile X Drug Finds Frustration, Hope

  • Download
  • <iframe src="https://www.npr.org/player/embed/371502800/372409645" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Icon Genetics' Dr. Frank Thieme selects samples of Nicotiana benthamiana, a relative of tobacco, growing in a company greenhouse in Halle, Germany. The company uses the plants to produce antibodies that could be helpful for increasing supplies of ZMapp. Sean Gallup/Getty Images hide caption

toggle caption
Sean Gallup/Getty Images

Answering Your Questions About Ebola Treatments And Vaccines

  • Download
  • <iframe src="https://www.npr.org/player/embed/355184997/355188002" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A man stands above a new Ebola treatment center in Monrovia, Liberia. Health workers in Liberia, the hardest-hit nation, have turned people away from treatment units because of shortages of beds and staff. Pascal Guyot/AFP/Getty Images hide caption

toggle caption
Pascal Guyot/AFP/Getty Images

A federal database, though imperfect, will make it easier for patients to find out about the ties between doctors and industry. John Bolesky/Corbis hide caption

toggle caption
John Bolesky/Corbis

4 Years Of Lessons Learned About Drugmakers' Payments To Doctors

  • Download
  • <iframe src="https://www.npr.org/player/embed/352522612/352538436" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Federal prosecutors allege two nursing homes in California have "persistently and severely overmedicated elderly and vulnerable residents." Antipsychotic drugs like risperidone, also known as Risperdal, can be dangerous for elderly people, but are frequently prescribed to nursing home patients. JB Reed/Bloomberg via Getty Images hide caption

toggle caption
JB Reed/Bloomberg via Getty Images

Feds Hope Hitting Nursing Homes In The Wallet Will Cut Overmedication

  • Download
  • <iframe src="https://www.npr.org/player/embed/346137537/346137538" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript